Prodrug strategies for targeted therapy triggered by reactive oxygen species
- 8 May 2019
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 10 (9) , 1531-1549
Abstract
A comprehensive review of ROS-activated produg strategies for targeted therapy, including state-of-the-art and future perspectives.Keywords
Funding Information
- Novo Nordisk Fonden
- Danmarks Tekniske Universitet
- Teknologi og Produktion, Det Frie Forskningsråd (7017-00026)
This publication has 142 references indexed in Scilit:
- ROS‐Inducible DNA Cross‐Linking Agent as a New Anticancer Prodrug Building BlockChemistry – A European Journal, 2012
- Hydrogen Peroxide Inducible DNA Cross-Linking Agents: Targeted Anticancer ProdrugsJournal of the American Chemical Society, 2011
- Boronate Oxidation as a Bioorthogonal Reaction Approach for Studying the Chemistry of Hydrogen Peroxide in Living SystemsAccounts of Chemical Research, 2011
- Activation of sulfonate ester based matrix metalloproteinase proinhibitors by hydrogen peroxideJBIC Journal of Biological Inorganic Chemistry, 2010
- Orally delivered thioketal nanoparticles loaded with TNF-α–siRNA target inflammation and inhibit gene expression in the intestinesNature Materials, 2010
- Hydrogen Peroxide Activated Matrix Metalloproteinase Inhibitors: A Prodrug ApproachAngewandte Chemie International Edition, 2010
- A Prochelator Activated by Hydrogen Peroxide Prevents Metal‐Induced Amyloid β AggregationChemBioChem, 2009
- Direct oxidation of boronates by peroxynitrite: Mechanism and implications in fluorescence imaging of peroxynitriteFree Radical Biology and Medicine, 2009
- Iron prochelator BSIH protects retinal pigment epithelial cells against cell death induced by hydrogen peroxideJournal of Inorganic Biochemistry, 2008
- Role of Quinones in ToxicologyChemical Research in Toxicology, 2000